{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:27:57Z","timestamp":1792250877941,"version":"4.4.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:00:00Z","timestamp":1588377600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bbadis.2018.07.018","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T12:42:09Z","timestamp":1532522529000},"page":"1019-1030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Animal models of portal hypertension"],"prefix":"10.1016","volume":"1865","author":[{"given":"P.","family":"K\u00f6nigshofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Brusilovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Schwabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2018.07.018_bb0005","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","author":"Pimpin","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-017-0806-8","article-title":"Non-alcoholic fatty liver disease","volume":"15","author":"Neuschwander-Tetri","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/labinvest.3700030","article-title":"Portal tract fibrogenesis in the liver","volume":"84","author":"Ramadori","year":"2004","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/cld.172","article-title":"Histopathology of alcoholic liver disease","volume":"2","author":"Theise","year":"2013","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bpg.2011.02.001","article-title":"Fibrosis in autoimmune and cholestatic liver disease","volume":"25","author":"Penz-Osterreicher","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0035","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0040","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00000658-197403000-00010","article-title":"Experimental study of hyperdynamic vs. stagnant mesenteric blood flow in portal hypertension","volume":"179","author":"Witte","year":"1974","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0045","first-page":"G52","article-title":"Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension","volume":"244","author":"Vorobioff","year":"1983","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0050","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3748\/wjg.v20.i10.2555","article-title":"Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis","volume":"20","author":"Bolognesi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2005.02.022","article-title":"Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats","volume":"43","author":"Fernandez","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0060","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1478-3231.2006.01308.x","article-title":"Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study","volume":"26","author":"Geerts","year":"2006","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0163-7258(01)00124-3","article-title":"The hyperdynamic circulation in cirrhosis: an overview","volume":"89","author":"Blendis","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0070","first-page":"254","article-title":"Portal hypertension","volume":"22","author":"Garcia-Tsao","year":"2006","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-017-9827-9","article-title":"The portal hypertension syndrome: etiology, classification, relevance, and animal models","volume":"12","author":"Bosch","year":"2018","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162144","article-title":"Novel rat model of repetitive portal venous embolization mimicking human non-cirrhotic idiopathic portal hypertension","volume":"11","author":"Klein","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0085","first-page":"376","article-title":"Production of hepatic outflow block and ascites with an ameroid constrictor","volume":"17","author":"Sweat","year":"1966","journal-title":"Surg. Forum"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0090","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1440-1746.2008.05403.x","article-title":"Early changes of the portal tract on microcomputed tomography images in a newly-developed rat model for Budd-Chiari syndrome","volume":"23","author":"Darwish Murad","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0095","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s12013-013-9654-0","article-title":"A canine model for IVC occlusive form of Budd-Chiari syndrome using endovascular technique","volume":"67","author":"Chen","year":"2013","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0100","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3892\/mmr.2013.1868","article-title":"Development of a canine model with diffuse hepatic vein obstruction (BuddChiari syndrome) via endovascular occlusion","volume":"9","author":"Shen","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0002-9610(92)90266-T","article-title":"Treatment of Budd-Chiari syndrome due to inferior vena cava occlusion by combined portal and vena caval decompression","volume":"163","author":"Orloff","year":"1992","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0110","article-title":"Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats","volume":"138","author":"K\u00f6nigshofer","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0115","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","article-title":"Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME","volume":"87","author":"Godoy","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0120","series-title":"The Principles of Humane Experimental Technique","author":"Russell","year":"1959"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0125","series-title":"Mouse and Rat Models of Induction of Hepatic Fibrosis and Assessment of Portal Hypertension","author":"Klein","year":"2017"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01002772","article-title":"Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections","volume":"11","author":"Junqueira","year":"1979","journal-title":"Histochem. J."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0135","first-page":"2261","article-title":"Semiquantitative evaluation of hepatic fibrosis by measuring tissue hydroxyproline","volume":"45","author":"Toyoki","year":"1998","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0140","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1023\/A:1005556328028","article-title":"Correlation between stellate cell activation and serum fibrosis markers in choline-deficient l-amino acid-defined diet-induced rat liver fibrosis","volume":"45","author":"Hironaka","year":"2000","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0145","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1440-1746.2007.05150.x","article-title":"Interstrain differences in susceptibility to non-alcoholic steatohepatitis","volume":"23","author":"Yamazaki","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0150","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/liv.12335","article-title":"Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype","volume":"34","author":"Farrell","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0023677212473717","article-title":"Gender and strain-specific differences in the development of steatosis in rats","volume":"47","author":"Stoppeler","year":"2013","journal-title":"Lab. Anim."},{"issue":"6","key":"10.1016\/j.bbadis.2018.07.018_bb0160","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2014.01.025","article-title":"Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats","volume":"60","author":"Schwabl","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0165","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2009.06.024","article-title":"Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats","volume":"51","author":"Reiberger","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0170","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/gut.2005.088013","article-title":"NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats","volume":"56","author":"Angermayr","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0175","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/0016-5085(95)90698-3","article-title":"Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats","volume":"108","author":"Fernandez","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0180","first-page":"G618","article-title":"Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model","volume":"248","author":"Sikuler","year":"1985","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0185","first-page":"G48","article-title":"Responses to hypotension in conscious rats with chronic portal venous hypertension","volume":"259","author":"Battarbee","year":"1990","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0190","first-page":"G52","article-title":"Portal venous pressure and portasystemic shunting in experimental portal hypertension","volume":"257","author":"Geraghty","year":"1989","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/cs0680023","article-title":"Effect of two models of portal hypertension on splanchnic organ blood flow in the rat","volume":"68","author":"Lebrec","year":"1985","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0200","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0016-5085(84)80072-4","article-title":"Increased blood flow through the portal system in cirrhotic rats","volume":"87","author":"Vorobioff","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0205","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000127720","article-title":"The porto-systemic collateral pattern in the rat. An angiographic and anatomical study after partial occlusion of the portal vein","volume":"6","author":"Halvorsen","year":"1974","journal-title":"Eur. Surg. Res."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0210","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2013.08.013","article-title":"Non-cirrhotic portal hypertension: diagnosis and management","volume":"60","author":"Khanna","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0215","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3748\/wjg.v4.i1.66","article-title":"A new rat model of portal hypertension induced by intraportal injection of microspheres","volume":"4","author":"Li","year":"1998","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0220","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1755-1536-6-19","article-title":"Experimental liver fibrosis research: update on animal models, legal issues and translational aspects","volume":"6","author":"Liedtke","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0225","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/path.1700750212","article-title":"Disturbances of structure and function in the liver as the result of biliary obstruction","volume":"75","author":"Cameron","year":"1958","journal-title":"J. Pathol. Bacteriol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0230","first-page":"85","article-title":"A quantitative assessment of the structural changes the rat's liver following obstruction of the common bile duct","volume":"57","author":"Johnstone","year":"1976","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0235","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.surg.2010.07.046","article-title":"Partial bile duct ligation in mice: a novel model of acute cholestasis","volume":"149","author":"Heinrich","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0240","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4254\/wjh.v4.i7.199","article-title":"A half century (1961\u20132011) of applying microsurgery to experimental liver research","volume":"4","author":"Aller","year":"2012","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jss.2009.08.010","article-title":"Reversible surgical model of biliary inflammation and obstructive jaundice in mice","volume":"164","author":"Kirkland","year":"2010","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0250","first-page":"1333","article-title":"Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat","volume":"137","author":"Abdel-Aziz","year":"1990","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0255","first-page":"305","article-title":"Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat","volume":"65","author":"Kountouras","year":"1984","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0260","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1001\/archsurg.1979.01370330086016","article-title":"Portal hypertension after bile duct obstruction: effect of bile diversion on portal pressure in the rat","volume":"114","author":"Franco","year":"1979","journal-title":"Arch. Surg."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0265","first-page":"G779","article-title":"Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome","volume":"272","author":"Fallon","year":"1997","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0270","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00204-015-1543-4","article-title":"Experimental models of liver fibrosis","volume":"90","author":"Yanguas","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0275","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.3748\/wjg.v12.i41.6577","article-title":"Animal models of portal hypertension","volume":"12","author":"Abraldes","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0280","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.510310306","article-title":"The role of portal pressure in the severity of bleeding in portal hypertensive rats","volume":"31","author":"Castaneda","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0285","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0016-5085(00)70370-2","article-title":"An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis","volume":"118","author":"Cho","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0290","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/micr.10153","article-title":"Comparative study of macro- and microsurgical extrahepatic cholestasis in the rat","volume":"24","author":"Aller","year":"2004","journal-title":"Microsurgery"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0295","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/00365529309096038","article-title":"A model of cholestasis in the rat, using a microsurgical technique","volume":"28","author":"Aller","year":"1993","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0300","first-page":"1237","article-title":"Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis","volume":"145","author":"Mauad","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0305","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ajpath.2014.10.013","article-title":"A new Mdr2(\u2212\/\u2212) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer","volume":"185","author":"Ikenaga","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0310","first-page":"633","article-title":"Carbon tetrachloride toxicity as a model for studying free-radical mediated liver injury","volume":"311","author":"Slater","year":"1985","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0315","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0023677215571192","article-title":"The carbon tetrachloride model in mice","volume":"49","author":"Scholten","year":"2015","journal-title":"Lab. Anim."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0320","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/713611034","article-title":"Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model","volume":"33","author":"Weber","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0325","series-title":"Experimental Models of Cirrhosis and Ascites","author":"Claria","year":"2007"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0330","first-page":"502","article-title":"Instant cirrhosis. An improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone","volume":"50","author":"McLean","year":"1969","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0335","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jhep.2009.09.008","article-title":"A novel model of CCl4-induced cirrhosis with ascites in the mouse","volume":"51","author":"Domenicali","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0340","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-2008-1040457","article-title":"Experimental models of hepatic fibrosis: a review","volume":"10","author":"Tsukamoto","year":"1990","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0345","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0023677215571192","article-title":"The carbon tetrachloride model in mice","volume":"49","author":"Scholten","year":"2015","journal-title":"Lab. Anim."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0350","first-page":"633","volume":"311","year":"1985","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0355","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors","volume":"102","author":"Iredale","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0360","first-page":"69","article-title":"Reversibility of hepatic fibrosis induced by carbon tetrachloride in the rat","volume":"29","author":"Varga","year":"1966","journal-title":"Acta Physiol. Acad. Sci. Hung."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0365","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1053\/gast.2002.37069","article-title":"Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15","volume":"123","author":"Hillebrandt","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0370","series-title":"Fibrosis Research: Methods and Protocols","first-page":"237","article-title":"Modeling liver fibrosis in rodents","author":"Constandinou","year":"2005"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0375","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.1934.02750390006003","article-title":"Carbon tetrachloride as an industrial hazard","volume":"103","author":"Davis","year":"1934","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0380","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1021\/tx3002719","article-title":"Metabolism and toxicity of thioacetamide and thioacetamide S-oxide in rat hepatocytes","volume":"25","author":"Hajovsky","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0385","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tox.2006.11.050","article-title":"Toxicokinetics and toxicity of thioacetamide sulfoxide: a metabolite of thioacetamide","volume":"230","author":"Chilakapati","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0390","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.tiv.2010.06.011","article-title":"The toxic effect of thioacetamide on rat liver in vitro","volume":"24","author":"Stankova","year":"2010","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0395","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1289\/ehp.95103260","article-title":"Tissue repair response as a function of dose in thioacetamide hepatotoxicity","volume":"103","author":"Mangipudy","year":"1995","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0400","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1440-1746.2006.04231.x","article-title":"Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models","volume":"21","author":"Natarajan","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0405","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1002\/pmic.200400852","article-title":"A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers","volume":"4","author":"Low","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0410","first-page":"199","article-title":"Changes in fatty acid composition of plasma, liver microsomes, and erythrocytes in liver cirrhosis induced by oral intake of thioacetamide in rats","volume":"21","author":"Moreira","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0415","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1440-1746.2012.07265.x","article-title":"Attenuation of hepatic fibrosis by an imidazolium salt in thioacetamide-induced mouse model","volume":"28","author":"Ding","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0420","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/hep.23435","article-title":"CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis","volume":"51","author":"Zaldivar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0425","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1755-1536-6-19","article-title":"Experimental liver fibrosis research: update on animal models, legal issues and translational aspects","volume":"6","author":"Liedtke","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0430","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/labinvest.2008.91","article-title":"Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice","volume":"88","author":"Salguero Palacios","year":"2008","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0435","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jhep.2004.04.010","article-title":"Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid","volume":"41","author":"Reif","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0440","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/carcin\/bgh037","article-title":"Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma","volume":"25","author":"Yeh","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0445","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/01926230590881808","article-title":"Tissue repair: an important determinant of final outcome of toxicant-induced injury","volume":"33","author":"Mehendale","year":"2005","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0450","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0455","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0460","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0465","doi-asserted-by":"crossref","first-page":"8364","DOI":"10.3748\/wjg.v20.i26.8364","article-title":"Experimental models of non-alcoholic fatty liver disease in rats","volume":"20","author":"Kucera","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0470","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000282097","article-title":"Animal models of non-alcoholic steatohepatitis: of mice and man","volume":"28","author":"Schattenberg","year":"2010","journal-title":"Dig. Dis."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0475","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1126\/science.113.2948.746","article-title":"Hereditary diabetes in genetically obese mice","volume":"113","author":"Mayer","year":"1951","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0480","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.113.2948.745.b","article-title":"Free selection of nutrients by hereditarily obese mice","volume":"113","author":"Mayer","year":"1951","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0485","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s10620-007-0193-7","article-title":"The transition from fatty liver to NASH associates with SAMe depletion in db\/db mice fed a methionine choline-deficient diet","volume":"53","author":"Wortham","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0490","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00429780","article-title":"Lipogenesis in situ in the genetically obese Zucker fatty rat (fa\/fa): role of hyperphagia and hyperinsulinaemia","volume":"14","author":"Godbole","year":"1978","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0495","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.metabol.2005.02.016","article-title":"Physiological difference between obese (fa\/fa) Zucker rats and lean Zucker rats concerning adiponectin","volume":"54","author":"Oana","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0500","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/hep.20282","article-title":"Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice","volume":"40","author":"Masaki","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0505","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI9238","article-title":"Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity","volume":"106","author":"Vaisse","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0510","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/5070","article-title":"Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides","volume":"21","author":"Marsh","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0515","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1101\/gad.12.20.3182","article-title":"Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy","volume":"12","author":"Shimomura","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0520","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.drudis.2017.06.007","article-title":"Mouse models of nonalcoholic steatohepatitis in preclinical drug development","volume":"22","author":"Hansen","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0525","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10620-009-0815-3","article-title":"Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats","volume":"55","author":"Xu","year":"2010","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0530","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1743-7075-4-4","article-title":"Long term highly saturated fat diet does not induce NASH in Wistar rats","volume":"4","author":"Romestaing","year":"2007","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0535","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1538\/expanim.56.263","article-title":"Involvement of sex, strain and age factors in high fat diet-induced obesity in C57BL\/6J and BALB\/cA mice","volume":"56","author":"Nishikawa","year":"2007","journal-title":"Exp. Anim."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0540","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1053\/j.gastro.2005.09.004","article-title":"NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis","volume":"129","author":"Dela Pena","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0545","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1478-3231.2006.01314.x","article-title":"Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis","volume":"26","author":"Rangnekar","year":"2006","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0550","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3164\/jcbn.08-256","article-title":"Beneficial effects of fermented green tea extract in a rat model of non-alcoholic steatohepatitis","volume":"44","author":"Nakamoto","year":"2009","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0555","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3164\/jcbn.09-29","article-title":"A novel animal model of nonalcoholic steatohepatitis (NASH): hypoxemia enhances the development of NASH","volume":"45","author":"Takayama","year":"2009","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0560","doi-asserted-by":"crossref","first-page":"G825","DOI":"10.1152\/ajpgi.00145.2011","article-title":"Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition","volume":"301","author":"Charlton","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0565","doi-asserted-by":"crossref","first-page":"11963","DOI":"10.3390\/ijms140611963","article-title":"In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD)","volume":"14","author":"Kanuri","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0570","doi-asserted-by":"crossref","first-page":"12931","DOI":"10.1038\/srep12931","article-title":"Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis","volume":"5","author":"Schierwagen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0575","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0580","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2009.03.025","article-title":"Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis","volume":"51","author":"Zhang","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0585","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbrc.2014.04.048","article-title":"Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis","volume":"448","author":"Wu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158156","article-title":"Antifibrotic effects of the dual CCR2\/CCR5 antagonist cenicriviroc in animal models of liver and kidney fibrosis","volume":"11","author":"Lefebvre","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0595","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/13543784.2018.1442436","article-title":"Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis","volume":"27","author":"Tacke","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0600","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1046\/j.1440-1746.2003.03198.x","article-title":"Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies","volume":"18","author":"Kirsch","year":"2003","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0605","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/liv.12101","article-title":"Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling","volume":"33","author":"Reiberger","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0610","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1046\/j.1365-2362.2003.01251.x","article-title":"Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats","volume":"33","author":"Heller","year":"2003","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0615","doi-asserted-by":"crossref","first-page":"7778","DOI":"10.3748\/wjg.v19.i43.7778","article-title":"Amelioration of carbon tetrachloride-induced cirrhosis and portal hypertension in rat using adenoviral gene transfer of Akt","volume":"19","author":"Deng","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0620","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tox.2012.10.025","article-title":"Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway","volume":"303","author":"Shi","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0625","doi-asserted-by":"crossref","first-page":"G605","DOI":"10.1152\/ajpgi.00222.2012","article-title":"Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury","volume":"304","author":"Perepelyuk","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0630","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/BF02936946","article-title":"Reduced gastric surface mucus layer in experimental portal hypertension","volume":"32","author":"Imanishi","year":"1997","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0635","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/hep.510280308","article-title":"Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats","volume":"28","author":"Sogni","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0640","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jhep.2005.04.017","article-title":"Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?","volume":"43","author":"Sansoe","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0645","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1499-3872(13)60047-8","article-title":"Desensitization of G-protein-coupled receptors induces vascular hypocontractility in response to norepinephrine in the mesenteric arteries of cirrhotic patients and rats","volume":"12","author":"Chen","year":"2013","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052683","article-title":"Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure","volume":"8","author":"Reboredo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0655","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2362.2006.01620.x","article-title":"A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited","volume":"36","author":"Laleman","year":"2006","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0660","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1136\/gut.2010.234666","article-title":"Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats","volume":"60","author":"Abramovitch","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0665","doi-asserted-by":"crossref","first-page":"G112","DOI":"10.1152\/ajpgi.00132.2013","article-title":"Vitamin D inhibits development of liver fibrosis in an animal model but cannot ameliorate established cirrhosis","volume":"308","author":"Abramovitch","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0670","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/0023677215573040","article-title":"Standard operating procedures in experimental liver research: thioacetamide model in mice and rats","volume":"49","author":"Wallace","year":"2015","journal-title":"Lab. Anim."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0675","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0168-8278(02)00011-9","article-title":"Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality","volume":"36","author":"Li","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0680","first-page":"227","article-title":"Anti-oxidative and anti-inflammatory effects of spirulina on rat model of non-alcoholic steatohepatitis","volume":"51","author":"Pak","year":"2012","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","article-title":"Mouse models in non-alcoholic fatty liver disease and steatohepatitis research","volume":"87","author":"Anstee","year":"2006","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0690","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/hep.28962","article-title":"A novel glucagon-like peptide 1\/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice","volume":"65","author":"Valdecantos","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0695","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/hep.20170","article-title":"Administration of the potent PPAR\u03b1 agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice","volume":"39","author":"Ip","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0700","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/ajcn\/79.3.502","article-title":"Model of nonalcoholic steatohepatitis","volume":"79","author":"Lieber","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0705","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/hep.20877","article-title":"Steatohepatitis induced by intragastric overfeeding in mice","volume":"42","author":"Deng","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0710","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.metabol.2012.06.008","article-title":"High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice","volume":"62","author":"Tsuchiya","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0715","series-title":"An Engineered FGF21 Variant, LY2405319, can Prevent Non-alcoholic Steatohepatitis by Enhancing Hepatic Mitochondrial Function","author":"Hee Lee","year":"2016"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0720","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3748\/wjg.v22.i8.2512","article-title":"Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice","volume":"22","author":"Yamamoto","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.07.018_bb0725","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/hep.26461","article-title":"Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"58","author":"Staels","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0730","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.25534","article-title":"Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats","volume":"55","author":"Yang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.07.018_bb0800","first-page":"367","article-title":"CCL4-induced liver cirrhosis and hepatocellular carcinoma in rats: relationship to plasma zinc, copper and estradiol levels","volume":"41","author":"Frezza","year":"1994","journal-title":"Hepatogastroenterology"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918302618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918302618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:46:44Z","timestamp":1760417204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443918302618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":147,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0925443918302618"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.07.018","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models of portal hypertension","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}